Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02140177 · ClinicalTrials.gov registry record
Ask Suicide-Screening Questions to Everyone in Medical Settings (asQ em): Development of a Suicide Risk Screening Instrument for Adult Medical Inpatients
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 740
- Enrollment target
NCT02140177 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 740 participants.
The verdict
NCT02140177 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 740 participants
- Enrollment target
Study Summary
Background: \- Suicide is the 10th leading cause of death for U.S. adults. Medically ill people are at an increased risk of suicide. Most people who have killed themselves went to a healthcare provider within 3 months of their death. More and more, hospitals are being asked to assess people for signs of suicide risk so that they can get the help they need. If nurses and doctors can find out who is at risk they can make sure these people get help in the hospital. The asQ em (Ask Suicide-Screening Questions to Everyone in Medical Settings) is a brief questionnaire. It was created to detect suicidal thoughts and behaviors in hospitalized people. Researchers would like to further develop this tool and figure out which are the best questions to ask patients. Objective: \- To determine the best questions for healthcare providers to ask people with medical illnesses to see if they are having suicidal thoughts or planning to hurt themselves. Eligibility: \- NIH Clinical Center patients over age 18. Design: * Participants will be asked questions about how they have been feeling in the past few weeks. They will be asked questions about depression, anxiety, and suicidal thoughts and behaviors. They also will be asked some background questions. * It will take approximately 15 to 30 minutes to answer the questions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 740 participants |
| Start Date | 2014-05-14 |
| Est. Completion | 2020-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02140177
The ClinicalTrials.gov registry entry for NCT02140177 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 740 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02140177 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02140177 about?
NCT02140177 is a clinical study titled "Ask Suicide-Screening Questions to Everyone in Medical Settings (asQ em): Development of a Suicide Risk Screening Instrument for Adult Medical Inpatients". Background: \- Suicide is the 10th leading cause of death for U.S. adults. Medically ill people are at an increased risk of suicide. Most people who have killed themselves went to a healthcare provider within 3 months of their death. More and more, hospitals are being asked to assess people for sig...
What is the current status of trial NCT02140177?
This trial is currently completed. The enrollment target is 740 participants. The study started on 2014-05-14. Estimated completion is 2020-02-28.
Who is sponsoring clinical trial NCT02140177?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.